Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It is a violation to ask Agora to review a violation!

One would have expected full due diligence to have been completed prior to the nomination of a candidate other than "I've spoken with him a few times, and he seems like a nice fellow who has done well in business."

Is it seriously being suggested that qualification for a replacement BoD is conditional on being a "nice fellow"?

Perhaps this explains why there has been no suggestions as to what a replacement BoD would do differently to increase shareholder value?

What personable qualities qualify the other intended members? A nice smile, perhaps?

.

.

.

Be well

Share
New Message
Please login to post a reply